As COVID-19 cases have increased in several countries, the World Health Organization (WHO) has updated its recommendations for mask use in public places, COVID-19 treatments, and clinical management.
As stated by the organization, this is a part of a constant process of examining such information while working with guideline development committees made up of independent, international specialists who take into account the most recent data as well as the changing epidemiology.
WHO continues to recommend the use of masks, similar to earlier recommendations.
If a COVID-19 patient tests negative on an antigen-based fast test, the organization suggests that they be freed from isolation as soon as possible.
Without testing, the revised guidelines recommend 10 days of isolation from the date of symptom start for patients who exhibit symptoms.
Previously, WHO advised that people be discharged 10 days after their symptoms began, plus at least three days after their symptoms had disappeared.
“Isolation of people with COVID-19 is an important step in preventing others from being infected. This can be done at home or at a dedicated facility, such as a hospital or clinic,” said WHO.
It extended its strong recommendation for the use of nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’).
Due to the likelihood of benefits and the lack of recorded side effects, pregnant or breastfeeding women with non-severe COVID-19 should consult with their doctor to evaluate whether they should take this medicine.
There are currently six proven treatment options for COVID-19 patients, three of which prevent hospitalization in high-risk individuals and three of which save lives in those with severe or critical diseases.
Yet, except for corticosteroids, global access to other medications remains inadequate.
add your comment
Terms of publication : Not to offend the writer, people, sacred things, or attack religions or the divine self, and refrain from racist incitement and insults.